15 participants
Safety, Efficacy and Pharmacokinetics of ThisCART19A in Patients With Refractory or Relapsed B Cell Lymphoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2022-09-10
- Start Date:
- 2022-09-02
- Completion:
- 2025-07-01
Conditions
- Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited, r/r B-NHL
Interventions
- DRUG
No Results Yet